 Anti-Bacterial Agents
"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 1 | 5 | | 1996 | 2 | 4 | 6 | | 1997 | 4 | 1 | 5 | | 1998 | 6 | 4 | 10 | | 1999 | 11 | 5 | 16 | | 2000 | 4 | 3 | 7 | | 2001 | 8 | 3 | 11 | | 2002 | 4 | 3 | 7 | | 2003 | 11 | 10 | 21 | | 2004 | 10 | 6 | 16 | | 2005 | 7 | 11 | 18 | | 2006 | 10 | 6 | 16 | | 2007 | 12 | 10 | 22 | | 2008 | 18 | 14 | 32 | | 2009 | 11 | 15 | 26 | | 2010 | 20 | 14 | 34 | | 2011 | 29 | 11 | 40 | | 2012 | 21 | 16 | 37 | | 2013 | 30 | 15 | 45 | | 2014 | 29 | 15 | 44 | | 2015 | 44 | 24 | 68 | | 2016 | 37 | 24 | 61 | | 2017 | 41 | 18 | 59 | | 2018 | 49 | 27 | 76 | | 2019 | 59 | 29 | 88 | | 2020 | 44 | 47 | 91 | | 2021 | 41 | 54 | 95 | | 2022 | 12 | 72 | 84 | | 2023 | 16 | 60 | 76 | | 2024 | 39 | 48 | 87 | | 2025 | 30 | 13 | 43 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Russell JN, Kos D, Yacoub E, Sies AN, Warr B, Jelinski M, Ruzzini A, Cameron ADS. Enhanced metagenomic surveillance for bovine respiratory disease pathogens and antimicrobial resistance by hybridization capture sequencing. Appl Environ Microbiol. 2025 Oct 22; 91(10):e0097725.
-
Huaman RJ, Mancha F, Anderson EL, April MD, Bebarta VS, Castaneto MS, Christians U, Darlington DN, Douin DJ, Glenn KR, Ke P, Kirkwood BJ, Long BJ, Maddry JK, Mendez J, Mireles AA, Ritter AC, Schauer KE, Schumaker AL, Smith MD, Wright FL, Ginde AA, Rizzo JA, Schauer SG. Antibiotic Concentrations After Massive Transfusion (ACME) Study: A Review of the Literature on Antibiotic Dosing During Transfusion and Study Protocol. J Spec Oper Med. 2025 Sep 01; 25(3):66-71.
-
Ramirez H, Al-Jarah T, Schowe SW, Resendiz MJE. 8-Oxo-7,8-dihydropurines as Building Blocks to Enhance the Selectivity of an RNA Aptamer for Aminoglycosides. ACS Chem Biol. 2025 Sep 19; 20(9):2328-2342.
-
Kunz Coyne AJ, Alosaimy S, Lucas K, Morrisette T, Molina KC, DeKerlegand A, Schrack MR, Kang-Birken SL, Hobbs ALV, Agee J, Perkins NB, Biagi M, Pierce M, Truong J, Andrade J, Bouchard J, Gore T, King MA, Pullinger BM, Claeys KC, Herbin S, Cosimi R, Tart S, Veve MP, Jones BM, Rojas LM, Feehan AK, Zhao JJ, Witucki P, Rybak MJ. Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes. Microbiol Spectr. 2025 Oct 07; 13(10):e0056525.
-
Lurie-Weinberger MN, Cohen A, Kon H, Kastel O, Keren-Paz A, Schwartz D, Lellouche J, Nutman A, Frenk S, Schechner V, Temkin E, Friberg LE, Daikos GL, Skiada A, Durante-Mangoni E, Yahav D, Leibovici L, Dickstein Y, Dishon Benattar Y, Paul M, Carmeli Y. Virulence factors are preserved within carbapenem-resistant Acinetobacter baumannii clades. Virulence. 2025 Dec; 16(1):2542489.
-
Graff KE, Galvez N, Lamb MM, Cortes R, Sanchez Villeda EA, Calvimontes DM, Melgar MA, Olson D, Asturias EJ, Dominguez SR. Evaluating the Clinical Impact of the BCID2 Panel and Antimicrobial Stewardship in Pediatric Bloodstream Infections: A Pragmatic Trial in Guatemala. Pediatr Infect Dis J. 2025 Nov 01; 44(11):1051-1058.
-
Sil M, Goswami A, Mukherjee D, Mukherjee N, Polikarpov I, Goswami A, Nag M, Lahiri D. Withaferin A and Withanolide A-mediated silver nanoparticles target bacterial motility, metabolism, and stress adaptation in E. coli. Nanomedicine. 2025 Aug; 68:102846.
-
Grießhammer A, de la Cuesta-Zuluaga J, Müller P, Gekeler C, Homolak J, Chang H, Schmitt K, Planker C, Schmidtchen V, Gallage S, Bohn E, Nguyen TH, Hetzer J, Heikenwälder M, Huang KC, Zahir T, Maier L. Non-antibiotics disrupt colonization resistance against enteropathogens. Nature. 2025 Aug; 644(8076):497-505.
-
Márquez-Friedrichs F, Nolly MB, Ferreyra A, Zuloaga L, Dominguez S, Secotaro A, Rathour VS, Damiani MT, Contreras L, Sánchez DG. Shifts in bla genes and Class 1 integron prevalence in beta-lactamase-producing bacteria before and after the COVID-19 pandemic in Mendoza, Argentina. Microbiol Spectr. 2025 Aug 05; 13(8):e0277124.
-
Singh S, Gumbo T, Wang JY, Boorgula GD, Burke A, Huang HL, McShane PJ, Amaro-Galvez R, Gross JE, Aryal S, Heysell SK, Srivastava S. Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease. J Infect Dis. 2025 Jul 11; 231(6):1521-1531.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|